Richard F. Thompson

Queen Mary University of London — United Kingdom

Neuroscience · Life Sciences

51h-index10.5kcitations216works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(55), Vestibular and auditory disorders(44), Memory and Neural Mechanisms(25), Glaucoma and retinal disorders(22), Ovarian cancer diagnosis and treatment(19)

Publications215 total

Serum bile acids are associated with native liver survival in patients with Alagille syndrome: results from the GALA study group
Journal of Hepatology·2023
Supplementary table S6 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Table S3 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Figure 2 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure Legends 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure 3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Table S3 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Figure 1 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure 3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Data from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary table S6 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Table S4 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary table S2 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Figure Legends 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary table S2 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Table S5 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Figure and Methods from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Table S1 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Supplementary Table S1 from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
Data from A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Michel Baudry(10), Jeansok J. Kim(8), Lu Chen(8), Shaowen Bao(8), Michael R. Foy(6), Tracey J. Shors(5), Roberta Dı́az Brinton(4), David J. Krupa(4), Judith K. Thompson(4), David G. Lavond(4), William Sun(3), Chanpreet Singh(3), Joseph E. Steinmetz(3), Paul F. Chapman(3), Georges Tocco(3), Caleb E. Finch(2), Hiroshi Gomi(2), Shigeyoshi Itohara(2), Xiaoning Bi(2), Craig Weiss(2)